Management of peptic ulcer disease
The period under review saw the landmark development of the publication of the Helicobacter pylori genome. There were at least three attempts at guiding the clinician with regard to selection of patients in need of therapy for H. pylori infection. Therapeutic strategies have evolved and include prot...
Gespeichert in:
| Veröffentlicht in: | Current opinion in gastroenterology 1998-11, Vol.14 (6), p.452-457 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 457 |
|---|---|
| container_issue | 6 |
| container_start_page | 452 |
| container_title | Current opinion in gastroenterology |
| container_volume | 14 |
| creator | Louw, Japie A Marks, I N |
| description | The period under review saw the landmark development of the publication of the Helicobacter pylori genome. There were at least three attempts at guiding the clinician with regard to selection of patients in need of therapy for H. pylori infection. Therapeutic strategies have evolved and include proton-pump inhibitor-based combination therapies. The controversy regarding the pathogenic potential of H. pylori strains continued, with no perfect marker being identified. The role of the organism in NSAID-associated disease was investigated also, yielding interesting results. |
| doi_str_mv | 10.1097/00001574-199811000-00006 |
| format | Article |
| fullrecord | <record><control><sourceid>wolterskluwer_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00001574_199811000_00006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00001574-199811000-00006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2476-6a284dc7c55b3502bbd504af62ff7e9823ef42007034448a9bdd8437d99d765c3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMouFb_w-I9OvneHKX4BRUveg7ZZGJXt92SbCn-e7dWvTmXYV54Bp6XkJrBFQNrrmEapoykzNqGsemi-0gfkYopwagBpY9JBVwbyoSxp-SslPeJ4RZkRS6f_Nq_4QrXYz2keoObsQv1tg-Y69gV9AXPyUnyfcGLnz0jr3e3L_MHuni-f5zfLGjg0miqPW9kDCYo1QoFvG2jAumT5ikZtA0XmCQHMCCklI23bYyNFCZaG41WQcxIc_gb8lBKxuQ2uVv5_OkYuL2r-3V1f67fkZ5QeUB3Qz9iLh_9dofZLdH349L9V5H4AnP7VLk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Management of peptic ulcer disease</title><source>Journals@Ovid Complete</source><creator>Louw, Japie A ; Marks, I N</creator><creatorcontrib>Louw, Japie A ; Marks, I N</creatorcontrib><description>The period under review saw the landmark development of the publication of the Helicobacter pylori genome. There were at least three attempts at guiding the clinician with regard to selection of patients in need of therapy for H. pylori infection. Therapeutic strategies have evolved and include proton-pump inhibitor-based combination therapies. The controversy regarding the pathogenic potential of H. pylori strains continued, with no perfect marker being identified. The role of the organism in NSAID-associated disease was investigated also, yielding interesting results.</description><identifier>ISSN: 0267-1379</identifier><identifier>EISSN: 1531-7056</identifier><identifier>DOI: 10.1097/00001574-199811000-00006</identifier><language>eng</language><publisher>Lippincott Williams & Wilkins, Inc</publisher><ispartof>Current opinion in gastroenterology, 1998-11, Vol.14 (6), p.452-457</ispartof><rights>1998 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Louw, Japie A</creatorcontrib><creatorcontrib>Marks, I N</creatorcontrib><title>Management of peptic ulcer disease</title><title>Current opinion in gastroenterology</title><description>The period under review saw the landmark development of the publication of the Helicobacter pylori genome. There were at least three attempts at guiding the clinician with regard to selection of patients in need of therapy for H. pylori infection. Therapeutic strategies have evolved and include proton-pump inhibitor-based combination therapies. The controversy regarding the pathogenic potential of H. pylori strains continued, with no perfect marker being identified. The role of the organism in NSAID-associated disease was investigated also, yielding interesting results.</description><issn>0267-1379</issn><issn>1531-7056</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQhoMouFb_w-I9OvneHKX4BRUveg7ZZGJXt92SbCn-e7dWvTmXYV54Bp6XkJrBFQNrrmEapoykzNqGsemi-0gfkYopwagBpY9JBVwbyoSxp-SslPeJ4RZkRS6f_Nq_4QrXYz2keoObsQv1tg-Y69gV9AXPyUnyfcGLnz0jr3e3L_MHuni-f5zfLGjg0miqPW9kDCYo1QoFvG2jAumT5ikZtA0XmCQHMCCklI23bYyNFCZaG41WQcxIc_gb8lBKxuQ2uVv5_OkYuL2r-3V1f67fkZ5QeUB3Qz9iLh_9dofZLdH349L9V5H4AnP7VLk</recordid><startdate>199811</startdate><enddate>199811</enddate><creator>Louw, Japie A</creator><creator>Marks, I N</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199811</creationdate><title>Management of peptic ulcer disease</title><author>Louw, Japie A ; Marks, I N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2476-6a284dc7c55b3502bbd504af62ff7e9823ef42007034448a9bdd8437d99d765c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Louw, Japie A</creatorcontrib><creatorcontrib>Marks, I N</creatorcontrib><collection>CrossRef</collection><jtitle>Current opinion in gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Louw, Japie A</au><au>Marks, I N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of peptic ulcer disease</atitle><jtitle>Current opinion in gastroenterology</jtitle><date>1998-11</date><risdate>1998</risdate><volume>14</volume><issue>6</issue><spage>452</spage><epage>457</epage><pages>452-457</pages><issn>0267-1379</issn><eissn>1531-7056</eissn><abstract>The period under review saw the landmark development of the publication of the Helicobacter pylori genome. There were at least three attempts at guiding the clinician with regard to selection of patients in need of therapy for H. pylori infection. Therapeutic strategies have evolved and include proton-pump inhibitor-based combination therapies. The controversy regarding the pathogenic potential of H. pylori strains continued, with no perfect marker being identified. The role of the organism in NSAID-associated disease was investigated also, yielding interesting results.</abstract><pub>Lippincott Williams & Wilkins, Inc</pub><doi>10.1097/00001574-199811000-00006</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0267-1379 |
| ispartof | Current opinion in gastroenterology, 1998-11, Vol.14 (6), p.452-457 |
| issn | 0267-1379 1531-7056 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00001574_199811000_00006 |
| source | Journals@Ovid Complete |
| title | Management of peptic ulcer disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A27%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20peptic%20ulcer%20disease&rft.jtitle=Current%20opinion%20in%20gastroenterology&rft.au=Louw,%20Japie%20A&rft.date=1998-11&rft.volume=14&rft.issue=6&rft.spage=452&rft.epage=457&rft.pages=452-457&rft.issn=0267-1379&rft.eissn=1531-7056&rft_id=info:doi/10.1097/00001574-199811000-00006&rft_dat=%3Cwolterskluwer_cross%3E00001574-199811000-00006%3C/wolterskluwer_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |